SCHEMBL5455460

SCHEMBL5455460

Cc1cc(C(C)(C)C)cc(C(C)(C)C)c1C(COP(O)O)c1c(C)cc(C(C)(C)C)cc1C(C)(C)C.OP(O)O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
TSHR P16473 1/20 0.34
TACR1 P25103 1/20 0.32
RXRA P19793 2/20 0.31
PPARG P37231 2/20 0.31
RARA P10276 1/20 0.31
RARB P10826 1/20 0.31
RARG P13631 1/20 0.31
RXRB P28702 1/20 0.31
RXRG P48443 1/20 0.31
HTR1D P28221 2/20 0.31
HTR1B P28222 1/20 0.31
TP53 P04637 1/20 0.31
CYP2D6 P10635 1/20 0.31
ALOX15 P16050 1/20 0.31
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29421164 0.98 ALDH1A1 (0.35) ALDH1A1CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL39015 0.98 ALDH1A1 (0.35) ALDH1A1CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL8913292 0.91 CYP1A2 (0.31) ALDH1A1CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL5455455 0.89 ALDH1A1 (0.35) ALDH1A1CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL2264850 0.87 SMN1; SMN2 (0.38) ALDH1A1CYP2C9CYP2C19TP53CYP2D6
SCHEMBL8919526 0.85 RXRA (0.31) ALDH1A1RXRAPPARGRARARARB
SCHEMBL460101 0.81 ALDH1A1 (0.36) ALDH1A1CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL7643760 0.81 CYP2C9 (0.32) CYP2C9CYP2C19CYP1A2CYP3A4TSHR
SCHEMBL23777298 0.75 ALDH1A1 (0.36) ALDH1A1CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL603636 0.75 ALDH1A1 (0.36) ALDH1A1CYP2C9CYP2C19CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070256352-A1 Substituted hexahydro-1,4-diazepin-5-ones and compositions stabilized therewith WOOD MERVIN G 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070256352-A1 Substituted hexahydro-1,4-diazepin-5-ones and compositions stabilized therewith CRY1, GPX4, CAND1 ALDH1A1 195/4885CYP2C9 1017/4885CYP2C19 1343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.